Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.
about
Cardiac Troponins in Dogs and CatsBrain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysisPathophysiology of sepsis-induced myocardial dysfunctionCardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studiesElevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosisEchocardiography practice, training and accreditation in the intensive care: document for the World Interactive Network Focused on Critical Ultrasound (WINFOCUS)Effects of early hemodynamic resuscitation on left ventricular performance and microcirculatory function during endotoxic shock.The association between pneumococcal pneumonia and acute cardiac events.Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness.Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction.A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses.Decreased cardiac excitability secondary to reduction of sodium current may be a significant contributor to reduced contractility in a rat model of sepsis.Comparison of outcomes from sepsis between patients with and without pre-existing left ventricular dysfunction: a case-control analysisCaspase-3 knock-down reverses contractile dysfunction induced by sepsis in adult rat ventricular myocytesNew insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patientsPro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells.Pathophysiology and treatment of septic shock in neonates.TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo.The non-cardiac use and significance of cardiac troponins.Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome.Prognosis of Troponin-Positive Patients with Non-Obstructive Coronary Artery Disease.Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adultsPredictors and outcomes of infection-related hospital admissions of heart failure patientsInhibition of mTORC1 renders cardiac protection against lipopolysaccharide.Reduced cardiac output in imported Plasmodium falciparum malariaToll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisitedRecent advances in natriuretic peptide researchStress-related cardiomyopathies.Sepsis-induced cardiomyopathy.Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction.Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program.Chronic heart failure and mortality in patients with community-acquired Staphylococcus aureus bacteremia: a population-based cohort studyN-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shockPrognostic value of B-type natriuretic peptide (BNP) and its potential role in guiding fluid therapy in critically ill septic patients.Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled TrialBench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis.Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia.Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level.Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice.
P2860
Q26774969-4B84CDAB-82DA-470D-97B4-677D0BB3CAF0Q27023778-2D538057-1A1E-4C6D-837F-CA17C35DE380Q28079058-E32AE659-C54F-4C47-B85C-39E5EAE05891Q28743162-71B75E08-667F-49E2-8C67-B2EB3767F0D4Q28749111-1925FFF7-DEEB-4168-B942-54F5F6A112AFQ30484722-B99EF483-B9AF-4B8E-9B4B-D6C8F174096AQ30658793-C5912531-FF97-4244-A6B8-EF2A9B9B359BQ33288215-71383242-890F-40E9-834D-6F38B84B8BFAQ33643868-D29A1C94-BEA5-4D22-8DE0-DDEE63882844Q33751030-1D8C47F4-92B9-4291-BA7E-64ED2940EBD8Q33751220-425DE1D9-2AD1-429D-ACDB-C099B5AE78B4Q33753546-1ACE4954-83B1-4A2A-8427-C5F4B0179647Q33754235-D9F96D66-1F81-45CE-BA78-01797B2195BFQ33812768-048C796D-4AF7-4446-BCFF-AC02EBE83FE4Q33821409-DB004E9B-3B6B-4F8F-ADA4-290981A75100Q33889566-860832A4-7D6A-4557-81DA-1F65D2275ED7Q33940492-E4D85AA0-9B2A-46EF-8705-CFD09D1D449FQ34255776-856FCD40-2615-425E-B25C-F26B400CF26AQ34425048-203D8D79-3E91-4212-8818-0112A6D9602DQ34486797-8AC39DBE-2178-40DC-BB33-E887AA12EDFAQ34693164-52DDB4C9-2401-47F0-9038-66034B7A6D9BQ34717444-5962B498-E2E9-420F-A263-7B59E84B8F08Q34979546-98438213-95AF-4B16-AD50-6F64414EDBB9Q35038438-3A642E49-6A71-4D1F-BF3A-6111BA27630DQ35089282-AB33F614-260F-422D-A46E-B2C67EFE6B8DQ35129034-1BFAF4F1-9FEC-44AC-B294-813E592CFBA4Q35138063-F44A154B-2D52-469C-AED6-3880055B9E65Q35459776-A63C4630-3B18-4030-8C55-57892D9A36FDQ35574245-9DC3CE5A-1B0B-4C79-924C-A6D0C52D143EQ35687065-343F1BB0-CCAF-490F-9E18-0C97CD134795Q36002854-1C491CE5-465B-46D5-8323-9569DDFCCBF5Q36009084-8A8FAABA-B614-4037-9E79-CC77765BB9A9Q36029722-C78B7810-AA10-4B59-A796-429D42D7E5F7Q36392546-613233D1-FFAF-46EA-900B-C3785FF38895Q36539076-F250BC40-D9BA-4D2A-A9E5-735A3652C7A7Q36883306-B4DC87C2-07DC-4E60-8AEA-4B762B0B4AF9Q36954654-7DB58E66-44BB-4879-8521-B35F94AAB13BQ37120814-FB0E4639-BD55-453B-9B9D-9B72F7F97211Q37166487-4E1CB274-4E3C-4DAB-BCB3-58203D195213Q37207281-7DA190BA-143F-4E11-8A21-510CB3A58425
P2860
Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@ast
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@en
type
label
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@ast
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@en
prefLabel
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@ast
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@en
P2093
P356
P1433
P1476
Sepsis-associated myocardial d ...... nins and natriuretic peptides.
@en
P2093
Hans Rickli
Micha Maeder
Peter Ammann
Thomas Fehr
P304
P356
10.1378/CHEST.129.5.1349
P407
P577
2006-05-01T00:00:00Z